Integra LifeSciences Q2 2026 Revenue Edges Up, Issues Guidance
Integra LifeSciences reported Q2 2026 revenues of $418.8 million and GAAP earnings per share of $0.06, reaffirming its 2026 organic revenue and adjusted EPS guidance.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day